About 1,948,327 results (3,093 milliseconds)

WO2004033626A2 - Hyperglycosylated hcg (invasive trophoblast ...

https://patents.google.com/patent/WO2004033626A2/en
If a woman is not pregnant but has an increased level of hCG it may indicate the presence of a gestational trophoblastic tumor. ... tumor; b. measuring an ...

EP0219870A2 - Method for the detection of a polypeptide subunit in ...

https://patents.google.com/patent/EP0219870A2/en
... tumors wherein all samples showed elevated levels of hCG and free beta-hCG subunit. [0094]. The presence of hCG in a female is indicative of either pregnancy ...

EP0636171B1 - Procedes recourant a des anticorps contre des ...

https://patents.google.com/patent/EP0636171B1/fr
Diagnostic differentiel du cancer par methode immunocytochimique reposant sur des anticorps ou des antiserums contre hcg.beta. CA2149731A1 (fr) *, 1994-06-13 ...

US9849176B2 - RS7 antibodies - Google Patents

https://patents.google.com/patent/US9849176B2/en
... raised against human non-small-cell lung carcinoma. The RS7 antigen has been ... HCG, HCG-beta, ferritin, PAP, PLAP, EGP-2, histone, cytokeratin ...

WO2003074569A2 - Bispecific antibody point mutations for ...

https://patents.google.com/patent/WO2003074569
Occasionally, a sub-unit of a tumor- associated marker is advantageously used to raise antibodies having higher tumor- specificity, e.g., the beta-subunit of ...

US9272057B2 - Combining radioimmunotherapy and antibody-drug ...

https://patents.google.com/patent/US9272057B2/en
Occasionally, a sub-unit of a tumor-associated marker is advantageously used to raise antibodies having higher tumor-specificity, e.g., the beta-subunit of ...

WO1988003174A1 - Immunometric assay for the detection of human ...

https://patents.google.com/patent/WO1988003174A1/en
The 145 amino acid beta subunit (beta hCG) of hCG has over 80% homology with ... In one patient treated for a testicular tumor, hCG values fell below ...

CN101429249A - Anti-human chorionic gonadotrophin beta subunit ...

https://patents.google.com/patent/CN101429249A/en
Since the non-trophoblastic tumor cell ectopic expression hCG of report such as Gailani, (ectopice hCG, ehCG) relation that takes place, develops with tumour ...

US4966753A - Immunotherapeutic methods and compositions ...

https://patents.google.com/patent/US4966753A/en
Specifically, alphafetoprotein (AFP), Carcinoembryonic antigen (CEA), and human chorionic gonadotropin (HCG) are oncofetal tumor markers widely used in the ...

US20050100543A1 - Multivalent carriers of bi-specific antibodies ...

https://patents.google.com/patent/US20050100543A1/en
Occasionally, a sub-unit of a tumor-associated marker is advantageously used to raise antibodies having higher tumor-specificity, e.g., the beta-subunit of ...

US7172751B2 - D-amino acid peptides - Google Patents

https://patents.google.com/patent/US7172751B2/en
Occasionally, a sub-unit of a tumor-associated marker is advantageously used to raise antibodies having higher tumor-specificity, e.g., the beta-subunit of ...

US8642330B2 - Antibody compositions, methods for treating ...

https://patents.google.com/patent/US8642330B2/en
biology of hCG in fertility and cancer; and C) vaccination strategies for immune targeting of hCG, including against hCG peptides, beta chain, or carbohydrates ...

US20160280738A1 - Novel peptides and combination of peptides ...

https://patents.google.com/patent/US20160280738A1/en
... raised the possibility of using a host's immune system to intervene in tumor growth. ... tumor specific TCR-alpha and/or TCR-beta chains. [0209]. To ...

WO2003074566A2 - Rs7 antibodies - Google Patents

https://patents.google.com/patent/WO2003074566A2/en
... raised against human non-small-cell lung carcinoma. The RS7 antigen has been ... HCG, HCG-beta, ferritin, PAP, PLAP, EGP-2, histone, cytokeratin ...

US20160280759A1 - Novel peptides and combination of peptides ...

https://patents.google.com/patent/US20160280759A1/en
US20160280759A1 - Novel peptides and combination of peptides for use in immunotherapy against various tumors - Google Patents.

US6339143B1 - Methods of using antibodies against hormone ...

https://patents.google.com/patent/US6339143B1/en
... hCG with its carbohydrate moieties intact. The monoclonal antibodies raised against the synthetic peptide bound hCG, desialylated hCG, and synthetic peptide ...

US8969304B2 - Compositions and methods for the prevention of ...

https://patents.google.com/patent/US8969304B2/en
High-affinity binding of hCG and LH causes secondary hormone or receptor ... CA2697070A1 2009-03-05 Methods of inhibiting tumor growth using beta 5 integrin ...

WO2005004809A2 - Multivalent carriers of bi-specific antibodies ...

https://patents.google.com/patent/WO2005004809A2/en
Occasionally, a sub-unit of a tumor-associated marker is advantageously used to raise antibodies having higher tumor-specificity, e.g., the beta-subunit of ...

US9611313B2 - Antibody-endostatin fusion protein and its variants ...

https://patents.google.com/patent/US9611313B2/en
(B) To test binding to EGFR antigen, EGFR+ A431 tumor cells were incubated with antibodies and bound antibodies were detected by anti-human IgG-FITC for ...

US20150086482A1 - Dye Conjugated Peptides for Fluorescent ...

https://patents.google.com/patent/US20150086482A1/en
Occasionally, a sub-unit of a tumor-associated marker is advantageously used to raise antibodies having higher tumor-specificity, e.g., the beta-subunit of ...